scispace - formally typeset
Journal ArticleDOI

Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors.

Reads0
Chats0
TLDR
In this article, the authors fused red blood cell membrane together with MCF-7 membrane and fabricated an erythrocyte-cancer (RBC-M) hybrid membrane-camouflaged melanin nanoparticle platform for enhancing therapeutic efficacy of photothermal therapy (PTT).
About
This article is published in Biomaterials.The article was published on 2019-02-01. It has received 241 citations till now. The article focuses on the topics: Membrane protein & Membrane.

read more

Citations
More filters
Journal ArticleDOI

Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance

TL;DR: The roles of nanoparticles and hybrid nanoparticles for drug delivery in chemotherapy, targeted therapy, and immunotherapy are discussed and the targeting mechanism of nanoparticle-based drug delivery as well as its function on reversing drug resistance are described.
Journal ArticleDOI

Cell Membrane Coating Technology: A Promising Strategy for Biomedical Applications

TL;DR: This review provides a comprehensive overview of the theory of cell membrane coating technology, followed by a summary of the existing preparation and characterization techniques, and focuses on the functions and applications of various cell membrane types.
Journal ArticleDOI

Molecular Targeting-Mediated Mild-Temperature Photothermal Therapy with a Smart Albumin-Based Nanodrug.

TL;DR: A smart albumin-based tumor microenvironment-responsive nanoagent designed via the self-assembly of human serum albumin, dc-IR825, and gambogic acid allows the release of molecular drugs more precisely, ablate tumors more effectively, and inhibit cancer metastasis more persistently, which will advance the development of novel mild-temperature PTT-based combination strategies.
Journal ArticleDOI

Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery

TL;DR: This review begins with an overview of different cell membranes that can be utilized to create a biointerface on nanoparticles and elaborate on the state-of-the-art of cell membrane biomimetic nanoparticles for drug delivery.
Journal ArticleDOI

Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications.

TL;DR: It is demonstrated that MM/RAPNPs could efficiently and safely inhibit the progression of AS and may be potential drug delivery systems for safe and effective anti-AS applications.
References
More filters
Journal ArticleDOI

Nanocarriers as an emerging platform for cancer therapy

TL;DR: The arsenal of nanocarriers and molecules available for selective tumour targeting, and the challenges in cancer treatment are detailed and emphasized.
Journal ArticleDOI

Cancer nanomedicine: progress, challenges and opportunities.

TL;DR: Novel engineering approaches are discussed that capitalize on the growing understanding of tumour biology and nano–bio interactions to develop more effective nanotherapeutics for cancer patients.
Journal ArticleDOI

Analysis of nanoparticle delivery to tumours

TL;DR: This Perspective explores and explains the fundamental dogma of nanoparticle delivery to tumours and answers two central questions: ‘ how many nanoparticles accumulate in a tumour?’ and ‘how does this number affect the clinical translation of nanomedicines?'
Journal ArticleDOI

Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

TL;DR: A top-down biomimetic approach in particle functionalization is reported by coating biodegradable polymeric nanoparticles with natural erythrocyte membranes, including both membrane lipids and associated membrane proteins for long-circulating cargo delivery.
Related Papers (5)